Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in postmenopausal women with insomnia
NCT05440734Terminated
- Sponsor
- Douglas Mental Health University Institute
- Start
- Jun 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of melatonin in Insomnia (2 arms), sponsored by Douglas Mental Health University Institute. Primary endpoints: Sleep duration at 15 days, Wake after sleep onset at 15 days and 2 more. Started Jun 2022; status: terminated.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT05440734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05440734.